Study: Intervention costs rise as glucose threshold is lowered

11/18/2013 | PhysiciansBriefing.com

Lowering the threshold for a normal fasting plasma glucose level may increase medical costs despite its potential benefit in diabetes prevention, CDC researchers noted in Diabetes Care. Researchers said lowering the glucose threshold may increase the cost per lifetime quality-adjusted life-year gained from $30,100 at 115 mg/dL to $115,800 at 90 mg/dL.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX